Ignite Creation Date:
2024-05-06 @ 8:08 AM
Last Modification Date:
2024-10-26 @ 11:56 AM
Study NCT ID:
NCT02675231
Status:
COMPLETED
Last Update Posted:
2024-03-19
First Post:
2016-02-03
Brief Title:
A Study of Abemaciclib LY2835219 in Women With HR HER2 Locally Advanced or Metastatic Breast Cancer
Sponsor:
Organization:
Eli Lilly and Company